Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09
Published August 3, 2016 · Recall initiated: July 11, 2016
Summary
FDA records drug Class II recall D-1448-2016, published August 3, 2016 and initiated July 11, 2016. Recalling firm: Actavis Inc; Status: Terminated; Reported quantity: 8,062 units; Lot: Lot #: 3803J141, Exp. 7/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if DEXTROAMPHETAMINE SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DEXTROAMPHETAMINE SULFATE
- Manufacturer
- Actavis Inc
- Distributor
- Nationwide
- UPC
- 0345963305091
- Lot
- Lot #: 3803J141, Exp. 7/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAcetylcyst 10% OPHT SOL, 10%, 15 mL bottle, Rx only, Medicap Pharmacy, 2790 W Cherry Lane, Meridian, ID 83642,August 3, 2016
- FDADivalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVAAugust 3, 2016
- FDAOxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - For IV Use, Sterile,August 3, 2016
- FDAAnspach G1 High Speed Electric Handpiece Air Cooled (eG1A) Use for cutting and shaping bone including bones ofJuly 27, 2016
- FDADextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by:March 11, 2015
- FDADextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NYJuly 2, 2014
Questions about this recall
Was Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles, Rx Only Manufactured by: Actavis Elizabeth LLC Elizabeth, NJ 07207 USA; Distributed by: Actavis Pharma, Inc Parsippany, NJ 07054 USA NDC 45963-304-09 recalled?
Yes. FDA published recall D-1448-2016 on August 3, 2016. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DEXTROAMPHETAMINE SULFATE. UPC: 0345963305091.